3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Malnutrition
3
Breast Neoplasms
2
Weight Gain
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Stomach Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Nutrition Disorders
1
Neoplasms
1
Muscular Atrophy
1
Motor Activity
1
Gastrointestinal Neoplasms
1
Fatigue
1
Cachexia
1
Interventions
Drug Therapy
4
apatinib
3
Oxaliplatin
3
pemigatinib
2
pembrolizumab
2
cemiplimab
2
avelumab
2
atezolizumab
2
S 1 (combination)
2
Nivolumab
2
Leucovorin
2
Irinotecan
2
Folfox protocol
2
Fluorouracil
2
Everolimus
2
Erlotinib Hydrochloride
2
Endoscopic Mucosal Resection
2
Docetaxel
2
Capecitabine
2
CGX1321
2
vandetanib
1
titanium silicide
1
tepotinib
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sodium thiosulfate
1
selpercatinib
1
rucaparib
1
pralsetinib
1
ponatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gastrointestinal Neoplasms
×
Diet Therapy
×
Clear all
NCT03670199
2021-09-13
PENDICOQ
University Hospital, Strasbourg, France
Phase NA
Unknown
200 enrolled